Benjamin Machinas Beneski

SVP, Chief Technical Officer, Allogene Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Mar 31, 2026

Companies

Allogene Therapeutics, Inc.SVP, Chief Technical Officer −$0.1M

Trades

ALLO Sold 2,867 shares at $2.50 $0.0M Mar 31

ALLO Sold 4,835 shares at $2.47 $0.0M Mar 16

ALLO Sold 7,132 shares at $2.60 $0.0M Mar 2

ALLO Sold 7,549 shares at $1.73 $0.0M Feb 2

ALLO Sold 786 shares at $1.22 $0.0M Nov 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.